Anti-CD1E antibody (ab136139)
- Product nameAnti-CD1E antibodySee all CD1E primary antibodies ...
- DescriptionRabbit polyclonal to CD1E
- Tested applicationsWB more details
- Species reactivityReacts with: Human
Predicted to work with: Mouse
Synthetic peptide corresponding to internal sequence amino acids of Human CD1E.
- Positive controlRAW264.7 cell lysate.
- Storage instructionsShipped at 4°C. Store at -20ºC.
- Storage bufferpH: 7.40
Preservative: 0.02% Sodium azide
Constituents: 49% PBS, 50% Glycerol, 0.88% Sodium chloride
Note: PBS without Mg2+ and Ca2+
- Concentration information loading...
- PurityImmunogen affinity purified
- Purification notesab136139 was affinity-purified from rabbit antiserum by immunogenic peptide affinity-chromatography.
- Clonality Polyclonal
- Research Areas
Our Abpromise guarantee covers the use of ab136139 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||WB: 1/500 - 1/1000. Predicted molecular weight: 44 kDa.|
- RelevanceT-cell surface glycoprotein CD1e, soluble is required for the presentation of glycolipid antigens on the cell surface. The membrane-associated form is not active.
- Cellular localizationT-cell surface glycoprotein CD1e, membrane-associated: Golgi apparatus membrane; Single-pass type I membrane protein. Early endosome. Late endosome. Note: Predominantly localized in the trans-Golgi network in immature dendritic cells, and as a cleaved, soluble protein in the lysosome lumen of mature dendritic cells. T-cell surface glycoprotein CD1e, soluble: Lysosome lumen
- CD_antigen=CD1e antibodyCD1A antibodyCD1e antigen antibody
- CD1E antigen, e polypeptide antibodyCD1e molecule antibodyDifferentiation antigen CD1-alpha-3 antibody
Anti-CD1E antibody images
Anti-CD1E antibody (ab136139) at 1/500 dilution + RAW264.7 cell lysate at 30 µg
Predicted band size : 44 kDa
References for Anti-CD1E antibody (ab136139)
ab136139 has not yet been referenced specifically in any publications.